Pyelonephritis during pregnancy: A cause for an acquired deficiency of protein Z

References

• Gilstrap L C III, Cunningham F G, Whalley P J. Acute pyelonephritis in pregnancy: An anterospective study. Obstet Gynecol 1981; 57: 409–413
   PubMed Web of Science ®Google Scholar
• Wing D A. Pyelonephritis. Clin Obstet Gynecol 1998; 41: 515–526
   PubMed Web of Science ®Google Scholar
• Bubeck R W. Acute pyelonephritis during pregnancy with anuria, septicemia and thrombocytopenia. Del Med J 1968; 40: 143–147
   PubMedGoogle Scholar
• Cunningham F G, Morris G B, Mickal A. Acute pyelonephritis of pregnancy: A clinical review. Obstet Gynecol 1973; 42: 112–117
   PubMed Web of Science ®Google Scholar
• Dilworth E E, Ward J V. Bacteremic shock in pyelonephritis and criminal abortion. Obstet Gynecol 1961; 17: 160–167
   PubMed Web of Science ®Google Scholar
• Mabie W C, Barton J R, Sibai B. Septic shock in pregnancy. Obstet Gynecol 1997; 90: 553–561
   PubMed Web of Science ®Google Scholar
• Ventura J E, Villa M, Mizraji R, Ferreiros R. Acute renal failure in pregnancy. Ren Fail 1997; 19: 217–220
   PubMed Web of Science ®Google Scholar
• Pruett K, Faro S. Pyelonephritis associated with respiratory distress. Obstet Gynecol 1987; 69: 444–446
   PubMed Web of Science ®Google Scholar
• Cunningham F G, Lucas M J, Hankins G D. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol 1987; 156: 797–807
   PubMed Web of Science ®Google Scholar
• Cunningham F G, Lucas M J. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol 1994; 8: 353–373
   PubMed Web of Science ®Google Scholar
• Catanzarite V A, Willms D. Adult respiratory distress syndrome in pregnancy: Report of three cases and review of the literature. Obstet Gynecol Surv 1997; 52: 381–392
   PubMedGoogle Scholar
• Hill J B, Sheffield J S, McIntire D D, Wendel G D, Jr. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005; 105: 18–23
   PubMed Web of Science ®Google Scholar
• Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 1998; 26: 2005–2009
   PubMed Web of Science ®Google Scholar
• Esmon C T, Fukudome K, Mather T, Bode W, Regan L M, Stearns-Kurosawa D J, Kurosawa S. Inflammation, sepsis, and coagulation. Haematologica 1999; 84: 254–259
   PubMed Web of Science ®Google Scholar
• Fernandez-Perez E R, Salman S, Pendem S, Farmer J C. Sepsis during pregnancy. Crit Care Med 2005; 33: S286–293
   Web of Science ®Google Scholar
• Corrigan J J, Jr, Ray W L, May N. Changes in the blood coagulation system associated with septicemia. N Engl J Med 1968; 279: 851–856
   PubMed Web of Science ®Google Scholar
• Hetland O, Brovold A B, Holme R, Gaudernack G, Prydz H. Thromboplastin (tissue factor) in plasma membranes of human monocytes. Biochem J 1985; 228: 735–743
   PubMed Web of Science ®Google Scholar
• Almdahl S M, Osterud B. Experimental Gram-negative septicemia: Thromboplastin generation in mononuclear phagocytes from different anatomical sites. Thromb Res 1987; 47: 37–46
   PubMed Web of Science ®Google Scholar
• Salgado A, Boveda J L, Monasterio J, Segura R M, Mourelle M, Gomez-Jimenez J, Peracaula R. Inflammatory mediators and their influence on haemostasis. Haemostasis 1994; 24: 132–138
   PubMedGoogle Scholar
• Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78: 759–764
   PubMed Web of Science ®Google Scholar
• Bouwman J J, Visseren F L, Bosch M C, Bouter K P, Diepersloot R J. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest 2002; 32: 759–766
   PubMed Web of Science ®Google Scholar
• Gando S, Kameue T, Matsuda N, Hayakawa M, Morimoto Y, Ishitani T, Kemmotsu O. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res 2003; 109: 119–124
   PubMed Web of Science ®Google Scholar
• Idell S, James K K, Levin E G, Schwartz B S, Manchanda N, Maunder R J, Martin T R, McLarty J, Fair D S. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84: 695–705
   PubMed Web of Science ®Google Scholar
• Bar-Shavit R, Kahn A, Wilner G D, Fenton J W. Monocyte chemotaxis: Stimulation by specific exosite region in thrombin. Science 1983; 220: 728–731
   PubMed Web of Science ®Google Scholar
• Bizios R, Lai L, Fenton J W, Malik A B. Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol 1986; 128: 485–490
   PubMed Web of Science ®Google Scholar
• Sonne O. The specific binding of thrombin to human polymorphonuclear leucocytes. Scand J Clin Lab Invest 1988; 48: 831–838
   PubMed Web of Science ®Google Scholar
• Drake W T, Issekutz A C. A role for alpha-thrombin in polymorphonuclear leukocyte recruitment during inflammation. Semin Thromb Hemost 1992; 18: 333–340
   PubMed Web of Science ®Google Scholar
• Drake W T, Lopes N N, Fenton J W, Issekutz A C. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. Lab Invest 1992; 67: 617–627
   PubMed Web of Science ®Google Scholar
• Naldini A, Carney D H, Bocci V, Klimpel K D, Asuncion M, Soares L E, Klimpel G R. Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 1993; 147: 367–377
   PubMed Web of Science ®Google Scholar
• Franchini M, Veneri D, Lippi G. Inflammation and hemostasis: A bidirectional interaction. Clin Lab 2007; 53: 63–67
   PubMed Web of Science ®Google Scholar
• Dery O, Corvera C U, Steinhoff M, Bunnett N W. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol 1998; 274: C1429–1452
   PubMed Web of Science ®Google Scholar
• Coughlin S R. Protease-activated receptors and platelet function. Thromb Haemost 1999; 82: 353–356
   PubMed Web of Science ®Google Scholar
• Coughlin S R. Thrombin signalling and protease-activated receptors. Nature 2000; 407: 258–264
   PubMed Web of Science ®Google Scholar
• Coughlin S R. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298–307
   PubMed Web of Science ®Google Scholar
• Landis R C. Protease activated receptors: Clinical relevance to hemostasis and inflammation. Hematol Oncol Clin North Am 2007; 21: 103–113
   PubMed Web of Science ®Google Scholar
• Camerer E, Huang W, Coughlin S R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000; 97: 5255–5260
   PubMed Web of Science ®Google Scholar
• Taylor F B, Chang A C, Peer G, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood 1998; 91: 1609–1615
   PubMed Web of Science ®Google Scholar
• Cunningham M A, Romas P, Hutchinson P, Holdsworth S R, Tipping P G. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999; 94: 3413–3420
   PubMed Web of Science ®Google Scholar
• Siegbahn A. Cellular consequences upon factor VIIa binding to tissue factor. Haemostasis 2000; 30(Suppl 2)41–47
   PubMedGoogle Scholar
• Asokananthan N, Graham P T, Fink J, Knight D A, Bakker A J, McWilliam A S, Thompson P J, Stewart G A. Activation of protease-activated receptor (PAR)- 1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002; 168: 3577–3585
   PubMed Web of Science ®Google Scholar
• Ruf W, Riewald M. Tissue factor-dependent coagulation protease signaling in acute lung injury. Crit Care Med 2003; 31: S231–237
   Web of Science ®Google Scholar
• Carraway M S, Welty-Wolf K E, Miller D L, Ortel T L, Idell S, Ghio A J, Petersen L C, Piantadosi C A. Blockade of tissue factor: Treatment for organ injury in established sepsis. Am J Respir Crit Care Med 2003; 167: 1200–1209
   PubMed Web of Science ®Google Scholar
• Hjortoe G M, Petersen L C, Albrektsen T, Sorensen B B, Norby P L, Mandal S K, Pendurthi U R, Rao L V. Tissue factor–factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004; 103: 3029–3037
   PubMed Web of Science ®Google Scholar
• Chu A J. Role of tissue factor in thrombosis. Coagulation–inflammation–thrombosis circuit. Front Biosci 2006; 11: 256–271
   PubMed Web of Science ®Google Scholar
• Chi L, Li Y, Stehno-Bittel L, Gao J, Morrison D C, Stechschulte D J, Dileepan K N. Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J Interferon Cytokine Res 2001; 21: 231–240
   PubMed Web of Science ®Google Scholar
• Camerer E, Kolsto A B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1–41
   PubMed Web of Science ®Google Scholar
• Rao L V, Rapaport S I. Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A 1988; 85: 6687–6691
   PubMed Web of Science ®Google Scholar
• ten Cate H, Bauer K A, Levi M, Edgington T S, Sublett R D, Barzegar S, Kass B L, Rosenberg R D. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993; 92: 1207–1212
   PubMed Web of Science ®Google Scholar
• Rodgers G M, Shuman M A. Prothrombin is activated on vascular endothelial cells by factor Xa and calcium. Proc Natl Acad Sci U S A 1983; 80: 7001–7005
   PubMed Web of Science ®Google Scholar
• Butenas S, Mann K G. Blood coagulation. Biochemistry (Mosc.) 2002; 67: 3–12
   PubMed Web of Science ®Google Scholar
• Lu G, Broze G J, Jr, Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: Differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem 2004; 279: 17 241–17 249
   Web of Science ®Google Scholar
• Han X, Fiehler R, Broze G J, Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci U S A 1998; 95: 9250–9255
   PubMed Web of Science ®Google Scholar
• Han X, Huang Z F, Fiehler R, Broze G J, Jr. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999; 38: 11 073–11 078
   Web of Science ®Google Scholar
• Han X, Fiehler R, Broze G J, Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049–3055
   PubMed Web of Science ®Google Scholar
• Yin Z F, Huang Z F, Cui J, Fiehler R, Lasky N, Ginsburg D, Broze G J, Jr. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A 2000; 97: 6734–6738
   PubMed Web of Science ®Google Scholar
• Kemkes-Matthes B, Nees M, Kuhnel G, Matzdorff A, Matthes K J. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res 2002; 106: 183–185
   PubMed Web of Science ®Google Scholar
• Martinelli I, Razzari C, Biguzzi E, Bucciarelli P, Mannucci P M. Low levels of protein Z and the risk of venous thromboembolism. J Thromb Haemost 2005; 3: 2817–2819
   PubMed Web of Science ®Google Scholar
• Fedi S, Sofi F, Brogi D, Tellini I, Cesari F, Sestini I, Gazzini A, Comeglio M, Abbate R, Gensini G F. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173–1178
   PubMed Web of Science ®Google Scholar
• Vasse M, Guegan-Massardier E, Borg J Y, Woimant F, Soria C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001; 357: 933–934
   PubMed Web of Science ®Google Scholar
• Koren-Michowitz M, Eting E, Rahimi-Levene N, Garach-Jehoshua O, Volcheck Y, Kornberg A. Protein Z levels and central retinal vein or artery occlusion. Eur J Haematol 2005; 75: 401–405
   PubMed Web of Science ®Google Scholar
• Gris J C, Quere I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606–2608
   PubMed Web of Science ®Google Scholar
• Bretelle F, Arnoux D, Shojai R, D'Ercole C, Sampol J, Dignat F, Camoin-Jau L. Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 2005; 193: 1698–1702
   PubMed Web of Science ®Google Scholar
• Paidas M J, Ku D H, Lee M J, Manish S, Thurston A, Lockwood C J, Arkel Y S. Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 2005; 3: 497–501
   PubMed Web of Science ®Google Scholar
• Alexander G R, Himes J H, Kaufman R B, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163–168
   PubMed Web of Science ®Google Scholar
• Prowse C V, Esnouf M P. The isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans 1977; 5: 255–256
   PubMed Web of Science ®Google Scholar
• Broze G J, Jr, Miletich J P. Human protein Z. J Clin Invest 1984; 73: 933–938
   PubMed Web of Science ®Google Scholar
• Tabatabai A, Fiehler R, Broze G J, Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655–660
   PubMed Web of Science ®Google Scholar
• Kemkes-Matthes B, Preissner K T, Langenscheidt F, Matthes K J, Muller-Berghaus G. S protein/vitronectin in chronic liver diseases: Correlations with serum cholinesterase, coagulation factor X and complement component C3. Eur J Haematol 1987; 39: 161–165
   PubMed Web of Science ®Google Scholar
• Yurdakok M, Gurakan B, Ozbag E, Vigit S, Dundar S, Kirazli S. Plasma protein Z levels in healthy newborn infants. Am J Hematol 1995; 48: 206–207
   PubMed Web of Science ®Google Scholar
• Al-Shanqeeti A, van Hylckmama V, Berntorp E, Rosendaal F R, Broze G J, Jr. Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost 2005; 93: 411–413
   PubMed Web of Science ®Google Scholar
• Quack Loetscher K C, Stiller R, Roos M, Zimmermann R. Protein Z in normal pregnancy. Thromb Haemost 2005; 93: 706–709
   PubMed Web of Science ®Google Scholar
• Kusanovic J P, Espinoza J, Romero R, Hoppensteadt D, Nien J K, Kim C J, Erez O, Soto E, Fareed J, Edwin S, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Med 2007; 20(6)453–463
   Google Scholar
• Lichy C, Kropp S, Dong-Si T, Genius J, Dolan T, Hampe T, Stoll F, Reuner K, Grond-Ginsbach C, Grau A. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 2004; 35: 40–45
   PubMed Web of Science ®Google Scholar
• Miletich J P, Broze G J, Jr. Human plasma protein Z antigen: Range in normal subjects and effect of warfarin therapy. Blood 1987; 69: 1580–1586
   PubMed Web of Science ®Google Scholar
• Vossen C Y, Hasstedt S J, Rosendaal F R, Callas P W, Bauer K A, Broze G J, Hoogendoorn H, Long G L, Scott B T, Bovill E G. Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost 2004; 2: 242–247
   PubMed Web of Science ®Google Scholar
• Kemkes-Matthes B, Matthes K J. Protein Z deficiency: A new cause of bleeding tendency. Thromb Res 1995; 79: 49–55
   PubMed Web of Science ®Google Scholar
• Gamba G, Bertolino G, Montani N, Spedini P, Balduini C L. Bleeding tendency of unknown origin and protein Z levels. Thromb Res 1998; 90: 291–295
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Espinoza J, Yoshimatsu J, Kim Y M, Bujold E, Edwin S, Yoon B H, Romero R. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11: 368–373
   PubMedGoogle Scholar
• Chaiworapongsa T, Yoshimatsu J, Espinoza J, Kim Y M, Berman S, Edwin S, Yoon B H, Romero R. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002; 11: 362–367
   PubMedGoogle Scholar
• Naccasha N, Gervasi M T, Chaiworapongsa T, Berman S, Yoon B H, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001; 185: 1118–1123
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, Buller H R. Bidirectional relation between inflammation and coagulation. Circulation 2004; 109: 2698–2704
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15: 254–259
   PubMed Web of Science ®Google Scholar
• Cavanagh D, Rao P S. Septic shock (endotoxic shock). Clin Obstet Gynecol 1973; 16: 25–39
   PubMedGoogle Scholar
• Ozge-Anwar A H, Freedman J J, Senyi A F, Cerskus A L, Blajchman M A. Enhanced prothrombin-converting activity and factor Xa binding of platelets activated by the alternative complement pathway. Br J Haematol 1984; 57: 221–228
   PubMed Web of Science ®Google Scholar
• Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004; 32: S293–297
   PubMed Web of Science ®Google Scholar
• Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015–1022
   PubMed Web of Science ®Google Scholar
• Semeraro N, Lattanzio A, Montemurro P, Papanice M, De Lucia O, De Bellis G, Giordano D. Mechanisms of blood clotting activation in inflammation: The role of mononuclear phagocytes. Int J Tissue React 1985; 7: 313–320
   PubMedGoogle Scholar
• Oeth P, Parry G C, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17: 365–374
   PubMed Web of Science ®Google Scholar
• Heyderman R S, Klein N J, Daramola O A, Hammerschmidt S, Frosch M, Robertson B D, Levin M, Ison C A. Induction of human endothelial tissue factor expression by Neisseria meningitidis: The influence of bacterial killing and adherence to the endothelium. Microb Pathog 1997; 22: 265–274
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006; 32: 33–39
   PubMed Web of Science ®Google Scholar
• Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 2004; 279: 23 038–23 044
   Web of Science ®Google Scholar
• Esmon C T. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417–430
   PubMed Web of Science ®Google Scholar
• Arias F, Rodriquez L, Rayne S C, Kraus F T. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168: 585–591
   PubMed Web of Science ®Google Scholar
• Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997; 89: 265–271
   PubMed Web of Science ®Google Scholar
• Welty-Wolf K E, Carraway M S, Ortel T L, Ghio A J, Idell S, Egan J, Zhu X, Jiao J A, Wong H C, Piantadosi C A. Blockade of tissue factor–factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol 2006; 290: L21–31
   PubMed Web of Science ®Google Scholar
• Busch G, Seitz I, Steppich B, Hess S, Eckl R, Schomig A, Ott I. Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: Implications in acute myocardial infarction. Arterioscler Thromb Vasc Biol 2005; 25: 461–466
   PubMed Web of Science ®Google Scholar
• Daubie V, Cauwenberghs S, Senden N H, Pochet R, Lindhout T, Buurman W A, Heemskerk J W. Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation. Biochim Biophys Acta 2006; 1763(8)860–869
   PubMed Web of Science ®Google Scholar
• Kemkes-Matthes B, Matthes K J. Protein Z. Semin Thromb Hemost 2001; 27: 551–556
   PubMed Web of Science ®Google Scholar
• Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Mazor M. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005; 17: 239–245
   PubMed Web of Science ®Google Scholar
• Soto E, Richani K, Romero R, Espinoza J, Chaiworapongsa T, Nien J K, Edwin S, Kim Y M, Hong J S, Goncalves L, et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2005; 17: 247–252
   PubMed Web of Science ®Google Scholar
• Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y. C5a induces tissue factor activity on endothelial cells. Thromb Haemost 1997; 77: 394–398
   PubMed Web of Science ®Google Scholar
• Sitrin R G, Kaltreider H B, Ansfield M J, Webster R O. Procoagulant activity of rabbit alveolar macrophages. Am Rev Respir Dis 1983; 128: 282–287
   PubMed Web of Science ®Google Scholar
• White B, Perry D. Acquired antithrombin deficiency in sepsis. Br J Haematol 2001; 112: 26–31
   PubMed Web of Science ®Google Scholar
• Martinez M A, Pena J M, Fernandez A, Jimenez M, Juarez S, Madero R, Vazquez J J. Time course and prognostic significance of hemostatic changes in sepsis: Relation to tumor necrosis factor-alpha. Crit Care Med 1999; 27: 1303–1308
   PubMed Web of Science ®Google Scholar
• Nawroth P P, Stern D M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740–745
   PubMed Web of Science ®Google Scholar
• Eckle I, Seitz R, Egbring R, Kolb G, Havemann K. Protein C degradation in vitro by neutrophil elastase. Biol Chem Hoppe Seyler 1991; 372: 1007–1013
   PubMed Web of Science ®Google Scholar
• Madden R M, Ward M, Marlar R A. Protein C activity levels in endotoxin-induced disseminated intravascular coagulation in a dog model. Thromb Res 1989; 55: 297–307
   PubMed Web of Science ®Google Scholar
• de Boer K, ten Cate J W, Sturk A, Borm J J, Treffers P E. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95–100
   PubMed Web of Science ®Google Scholar
• Yuen P M, Yin J A, Lao T T. Fibrinopeptide A levels in maternal and newborn plasma. Eur J Obstet Gynecol Reprod Biol 1989; 30: 239–244
   PubMed Web of Science ®Google Scholar
• Sorensen J D, Secher N J, Jespersen J. Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. A possible link to placental function. Acta Obstet Gynecol Scand 1995; 74: 257–261
   PubMed Web of Science ®Google Scholar
• Walker M C, Garner P R, Keely E J, Rock G A, Reis M D. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997; 177: 162–169
   PubMed Web of Science ®Google Scholar
• Bellart J, Gilabert R, Miralles R M, Monasterio J, Cabero L. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998; 46: 17–21
   PubMed Web of Science ®Google Scholar